Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Delivering purposeful solutions at Obesity Week 2025

    October 9, 2025 | Obesity Week 

    We’re attending Obesity Week 2025, the world’s leading event dedicated to obesity research and care, to showcase how our integrated expertise is advancing progress in obesity and cardiometabolic health.

    - PMLiVE

    Obesity Week 2025 is the premier global event dedicated to obesity research, prevention, and care – bringing together leading scientists, clinicians, and innovators to advance progress in one of the most dynamic areas of healthcare.​

    At Inizio, we’re uniting science, strategy, and creativity to deliver purposeful solutions across obesity and cardiometabolic health. Our integrated teams collaborate across the full commercialization journey to help clients navigate complexity, unlock value, and enhance outcomes at every stage of development and delivery.​

    Our experience spans the full obesity ecosystem: we’ve supported over 20 leading anti-obesity therapies, partnered on 80% of the largest GLP-1 assets, and worked across 18 specialized services to deliver smarter, connected solutions that make an impact.​

    Visit us at booth #812 to meet our experts and explore how Inizio’s integrated expertise is transforming the future of obesity and cardiometabolic care.​

    If you’d like to meet with us at Obesity Week, please get in touch.

    This content was provided by Inizio

    Company Details

    - PMLiVE

    Inizio

    Email
    Website

     Latest Content from  Inizio 

    Connected Patients – Adopting a patient-centric approach in emerging markets

    The concept of patient centricity and putting the patient at the heart of care is being widely adopted by the healthcare industry – the general consensus being that it’s going...

    Combination therapies in oncology: The benefits of integrated insights

    14 June 2018 11am EDT | 8am PDT | 4pm BST | 5pm CE

    Intellus round up 2018

    Earlier this month, US President Harriet Kozak and Emerging Markets Director Rachel Howard attended the inaugural Intellus Worldwide Summit in Philadelphia

    Janssen & Research Partnership win prestigious BHBIA Best Business Impact award

    We are delighted to announce that Janssen and Research Partnership have won the BOBI (Best of Business Intelligence) Award in the Best Business Impact category at the BHBIA annual conference in London for our collaborative market research...

    PEGASUS PHARMA TEAM GOES FROM STRENGTH TO STRENGTH WITH NEW APPOINTMENTS AND SENIOR PROMOTIONS

    Growth trend continues at Pegasus with six new appointments and five promotions in the Pharma and Life Sciences team

    How published research underpinned a cancer therapy awareness campaign

    Our client markets a product for Oral Mucositis (OM) - a side effect of cancer treatment - and wanted to better understand the disease and treatment challenges faced by both...

    How integrated insights supported a biologic launch strategy across multiple indications

    Our client is launching a new biologic in dermatology across indications and needed to understand the market, including the patient pool, treatment landscape, potential uptake and pricing opportunity for their...

    How a hybrid approach delivered fast insights to feed into an oncology product’s adoption strategy

    Our client wanted to quantify how ovarian cancer patients are managed prior to product launch, but also needed to understand why patients do or do not receive key diagnostic tests...

    Oncology experience & expertise

    Did you know 25% of our business is in Oncology?

    First, we need to talk: mental healthcare in the MENA region

    In our final installment of articles exploring mental health in emerging markets, we take an in-depth look at the situation in the MENA region